26 Dec, EOD - Indian

SENSEX 78472.48 (0.00)

Nifty 50 23750.2 (0.10)

Nifty Bank 51170.7 (-0.12)

Nifty IT 43664.25 (-0.01)

Nifty Midcap 100 57125.7 (0.12)

Nifty Next 50 69165.85 (0.45)

Nifty Pharma 22712.55 (0.68)

Nifty Smallcap 100 18728.65 (-0.02)

26 Dec, EOD - Global

NIKKEI 225 39568.06 (1.12)

HANG SENG 20098.29 (1.08)

S&P 6042.59 (-0.04)

Login/Signup
LOGIN HERE
Cancel

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
11-Dec-2024 11-Dec-2024 Half Yearly Results Outcome of Board Meeting held today i.e. 11th December, 2024
11-Oct-2024 11-Oct-2024 Change in Directors Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 11th October, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055 which commenced at 5:30 P. M. and concluded at 7:00 P.M. inter-alia has, considered and approved appointment of Mr. Nirav Soni (DIN: 08317653) as Additional Non-Executive and Non-Independent Director of the Company w.e.f. 11th October, 2024. The details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated 11/07/2023 are given in Annexure A. Kindly take the same on your record and oblige us
18-Sep-2024 18-Sep-2024 Stock Split Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e., Wednesday, 18th September, 2024 which commenced at 05:00 P.M. and concluded at 05:30 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, has decided to withdraw the Split/ Sub-division of Equity Shares of the Company from face value of Rs. 10/- each to face value of Re. 1/- each, which was approved by Shareholders in the Annual General Meeting held on 27th August, 2024. Kindly note that, the face value of Equity share of the Company will be Rs. 10/- (Rupees Ten Only).
24-Jul-2024 29-Jul-2024 Preferential Issue Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 29th July 2024 at 03:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider agenda mentioned in the Intimation. Pursuant to the Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Monday, 29th July, 2024 which commenced at 03:00 P.M. and concluded at 06:30 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, Gujarat, inter-alia considered and approved agenda''s mentioned in the attached outcome. (As Per BSE Announcement Dated on: 29/07/2024)
10-Jun-2024 12-Jun-2024 Accounts Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 12th June 2024 at 3:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India - 380 055 inter-alia to consider and approve the Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2024 along with Auditor Report. Pursuant to Regulations 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 12th June, 2024, at the registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380055, which commenced at 3:00 P.M. and concluded at 9:40 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report. (As Per BSE Announcement Dated on: 12/06/2024)
08-Apr-2024 06-May-2024 Bonus Issue Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Friday 26th April 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. (As Per BSE Announcement Dated on: 25/04/2024) Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024 Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. The proposal of sub-division of equity shares of the Company. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice. (As Per BSE Announcement Dated on 02.05.2024) Outcome of Board Meeting held on 6th May, 2024 (As per BSE Announcement Dated on 06/05/2024)
29-Mar-2024 28-Mar-2024 Right Issue Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ('the Regulations'), we hereby inform you that the Rights Issue Committee of Directors of the Company in their meeting held on Thursday, 28th March, 2024 at the Registered Of??ice of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 4:00 P.M. and concluded at 6:00 P.M. inter-alia had considered and approved as per attachment. Read less..
19-Mar-2024 19-Mar-2024 Right Issue With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 19th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Tuesday, 19th March, 2024 has now been extended by the Company from Tuesday, 19th March, 2024 to Wednesday, 20th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 03:00 P.M.
15-Mar-2024 15-Mar-2024 Right Issue With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 15th March, 2024 the date of closure of the captioned Right Issue, which had opened on Monday, 26th February, 2024 and scheduled to close on Friday, 15th March, 2024 has now been extended by the Company from Friday, 15th March, 2024 to Tuesday, 19th March, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. The meeting of the Board of Directors commenced at 10:00 A.M. and concluded at 11:00 A.M. Read less.
06-Mar-2024 06-Mar-2024 Right Issue Extension of issue closing date of Rights Issue from 07/03/2024 to 15/03/2024.
31-Jan-2024 31-Jan-2024 Right Issue Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in consultation with the Rights Issue Committee in their meeting held today i.e. 31st January, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, which commenced at 5:00 P.M. and concluded at 7:00 P.M. inter-alia has considered and approved issue upto 1,29,67,500 Equity Shares of face value of Rs. 10.00/- each for cash at an Issue Price of Rs. 10.00/- per Equity Share aggregating upto Rs. 12,96,75,000/- to all the existing eligible Equity shareholders of the Company on Rights ('Rights Issue'). The brief term of Rights Issue is approved by the Board is attached herewith as Annexure - I.
15-Dec-2023 15-Dec-2023 Change in Other Executives Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e. Friday, 15th December, 2023 at the Registered Office of the Company which commenced at 5:00 P.M. and concluded at 6:30 P.M inter-alia has considered and approved Appointment of Ms. Madhuri Gurwani as Company secretary and Compliance Officer of the Company w.e.f 15th December, 2023. Appointment Of Company Secretary
08-Dec-2023 08-Dec-2023 EGM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e. Friday, 8th December, 2023 at the Registered Office of the Company which commenced at 11:00 A.M. and concluded at 12:00 P.M inter-alia has: 1. Considered and approved increase in Authorised Share Capital upto Rs. 25,00,00,000/- (Rupees Twenty-Five Crores Only) by alteration of the capital clause in the Memorandum of Association of the Company. 2. Decided to hold Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company on Wednesday, 3rd January, 2024 at 12:00 P.M.
05-Oct-2023 18-Oct-2023 Right Issue Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 11th October 2023 at 4:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad-380055 inter-alia to discuss consider and approve: 1. Issue of Equity shares of the Company on Rights basis. 2. Unaudited Financial Results for half year ended on 30th September 2023 along with Limited Review Report. Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company which was to be held on Wednesday, 11th October, 2023 at 4:00 P.M, but due to unavoidable circumstances has been stands postponed on 18th October, 2023 at the same time and venue inter-alia to discuss, consider and approve: 1. Issue of Equity shares of the Company on Rights basis. 2. Unaudited Financial Results for half year ended on 30th September, 2023 along with Limited Review Report. (As per BSE Announcement Dated on 16/10/2023) Outcome of Board Meeting held on today i.e. 18th October, 2023 Submission of Unaudited Financial Results for the half year ended on 30th September, 2023 (As Per BSE Announcement dated on 18.10.2023)
06-Sep-2023 06-Sep-2023 AGM Outcome of Board Meeting held today i.e., 6th September, 2023
1 2